Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 400
Selected: 0
NCT IDTitle
NCT06990776A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects
NCT06662760Clinical Trial of TQB3002 in Patients With Advanced Cancers
NCT05333276Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers
NCT03461627Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
NCT05489276Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors
NCT04340427A Study of TQB3455 Tablets in Subjects With Advanced Malignancies
NCT06672276To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency
NCT05400876To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma
NCT06730620Bioequivalence Study of Methacholine Chloride
NCT04002622Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma
NCT07043725A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
NCT06300320A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
NCT06165822A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
NCT05405439To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer
NCT06566586A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
NCT06566248A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
NCT05815862Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer
NCT04439890A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer
NCT06431490A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT05610202Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects
NCT04412564A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor
NCT05894421TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
NCT02944864A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics
NCT03735264Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer(ALTER-L034)
NCT05068921A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy
NCT05783921A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma
NCT04337879A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
NCT04964479A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
NCT04574284A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
NCT03855384Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN)
NCT05675202Material Balance Study of TQ-B3525
NCT06115902A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
NCT06897579Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer
NCT06829784TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
NCT06738979A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
NCT06748079A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease
NCT06469879A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
NCT05353179Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
NCT04408079A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets
NCT04324879A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)
NCT06198764A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection
NCT05687864Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging
NCT06496490A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
NCT06143423A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
NCT06431438Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets
NCT03996408Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma
NCT03778138Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC
NCT01833923A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
NCT03766490Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer
NCT06150014A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B